Clinical Trials

Accrual Status
Limit to SWOG Trials

1037 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed S0727 Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 3/1/2008 9/1/2010 100% Published
Closed S0205 PANCREATIC 1/1/2004 4/1/2006 100% Published
Closed S1107 Papillary Renal, ARQ 197 +/- Erlotinib, Ph II 8/20/2012 5/29/2014 71%
Open S2001 Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects 12/4/2020 80%
Closed S0437 PCPT Long Term Follow Up 9/1/2005 3/1/2009 53%
Closed S0224 Penile 10/15/2004 11/15/2005 5%
Closed S1505 Perioperative FOLFIRINOX vs Gem/nab-Pac for Resectable Panc Adeno 10/12/2015 98%
Closed S9909 PET Imaging Ancillary to S9900 in NSCLC 12/15/1999 5/15/2001 1%
Closed S0905 Ph I / Randomized Ph II Mesothelioma Cediranib 3/15/2010 2/15/2016 91% Published
Closed S1313 Ph Ib/II Rando mFOLFIRINOX+PEGPH20 vs mFOLFIRINOX Alone in Good PS Met Pancreatic Adenocarcinoma 1/6/2014 73%
Closed S1702 Ph II AL amyloidosis isatuximab 3/8/2018 9/30/2019 100%
Closed S1605 Ph II Atezolizumab Local Bladder 2/7/2017 85%
Closed S1416 Ph II Cisplatin +/- ABT 888 in Metastatic TNBC and/or BRCA 7/7/2016 6/15/2019 100%
Open S2114 Ph II consolidation therapy following CD19 CAR-T for R/R DLBCL or Gr III FL 2/23/2023 36%
Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
Closed S1801 Ph II Ramdomization for Clinically Detectable Stage III-IV High-risk Melanoma 12/6/2018 5/5/2022 100%
Closed S0713 Ph II Rectal Pre-Operative ChemoRT 2/1/2009 4/15/2013 94% Published
Closed S1507 Ph II Tram + doce with kras NSCLC + and PD 7/18/2016 3/15/2018 100%
Open S1918 Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL 3/19/2021 32%
Closed S0927 Ph III Omega-3 fatty acid/placebo Breast Cancer 2/1/2012 2/1/2013 100% Published
Scroll Table